Endogena Therapeuticsincis A Clinical Stage Biotechnology Company Dedicated To Developing Innovative Regenerative Medicines Aimed At Repairing And Regenerating Tissues And Organsthe Company Focuses On Addressing Degenerative Conditions Related To Aging And Genetic Disorders By Using Small Molecules To Selectively Regulate Endogenous Adult Stem And Progenitor Cellsthis Approach Seeks To Enable Controlled Tissue Repair Without The Need For Invasive Procedures Headquartered In Za Richswitzerlandwith Legal Registration In San Franciscousaand A Research Facility In Torontocanadaendogena Has Advanced Its Clinical Programs Since Transitioning To Clinical Stage Development In 2022The Company Is Currently Conducting Clinical Trials For Its Lead Programs Targeting Retinitis Pigmentosa And Geographic Atrophya Condition Associated With Age Related Macular Degenerationendogena S Therapies Aim To Benefit Patients Suffering From These Degenerative Eye Diseaseshighlighting Its Commitment To Advancing Regenerative Medicine Through Collaboration With Regulatory Bodies And Healthcare Providers
No conferences found for this company.
| Company Name | Endogena Therapeutics Inc |
| Country |
Canada
|
| Address | N/A |
| Telephone | N/A |
| N/A |
